bpc-157 human trials results Peptides in Orthopedics: What to Know Regeneration or Risk? A Narrative

Preclinical studies indicate that BPC-157 promotes the healing of skin, mucosa, cornea, muscle, tendon, ligament, and bone in animal models

this designation is unrelated to research use Intended strictly for laboratory research use

The long-acting formulation means that cagrilintide maintains therapeutic levels for extended periods, making it suitable for weekly administration protocols in research settings

A slight foaming on the surface is normal if you swirled too vigorously

Additional animal injury models highlight the anti-inflammatory and pain reduction properties of BPC-157 [12, 13]

We were looking at these rodent studies, and were like, these look really promising. And were doing the math on species conversions to figure out human doses. Nobody was under the illusion that what they were doing was definitively safe, he continued